Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 4—April 2009
Dispatch

Enterovirus 71 Maternal Antibodies in Infants, Taiwan

Shu-Ting Luo, Pai-Shan Chiang, An-Shine Chao, Guan-Yuan Liou, Reyin Lin, Tzou-Yien Lin, and Min-Shi LeeComments to Author 
Author affiliations: National Health Research Institutes, Zhunan Miaoli, Taiwan (S.-T. Luo, P.-S. Chiang, G.-Y. Liou, M.-S. Lee); Chang Gung Memorial Hospital, Linkou, Taiwan (A.-S. Chao, R. Lin, T.-Y. Lin)

Main Article

Figure 2

Predicted seroprevalences of maternal enterovirus 71 (EV71) neutralizing antibodies (antibody titer >8) in infants <6 months of age, Taiwan. Predictions are based on assumptions that 1) the seroprevalence in neonates is 50%, 2) the geometric mean titer (SD after natural logarithm transformation) in the seropositive neonates is 22 (0.91), and 3) the half-life of maternal EV71 neutralizing antibodies in young infants is 42 days.

Figure 2. Predicted seroprevalences of maternal enterovirus 71 (EV71) neutralizing antibodies (antibody titer >8) in infants <6 months of age, Taiwan. Predictions are based on assumptions that 1) the seroprevalence in neonates is 50%, 2) the geometric mean titer (SD after natural logarithm transformation) in the seropositive neonates is 22 (0.91), and 3) the half-life of maternal EV71 neutralizing antibodies in young infants is 42 days.

Main Article

Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external